Tatva Chintan Pharma Chem Limited

Equities

TATVA

INE0GK401011

Specialty Chemicals

End-of-day quote NSE India S.E. 03:30:00 07/06/2024 am IST 5-day change 1st Jan Change
1,027 INR +1.05% Intraday chart for Tatva Chintan Pharma Chem Limited -0.65% -35.88%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024
Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Tatva Chintan Pharma Chem Limited Accords Environmental Clearance to for Setting Up Plant for Manufacturing of Chemicals CI
Certain Equity Shares of Tatva Chintan Pharma Chem Limited are subject to a Lock-Up Agreement Ending on 25-FEB-2024. CI
Transcript : Tatva Chintan Pharma Chem Limited, Q3 2024 Earnings Call, Jan 20, 2024
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Tatva Chintan Pharma Chem Limited, Q2 2024 Earnings Call, Nov 02, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Crisil Affirms A- Rating on Tatva Chintan Pharma Chem's Debt Financing; Outlook Stable MT
Transcript : Tatva Chintan Pharma Chem Limited, Q1 2024 Earnings Call, Aug 04, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tatva Chintan Pharma Chem's Consolidated Profit Shrinks in Fiscal Q4 MT
Transcript : Tatva Chintan Pharma Chem Limited, Q4 2023 Earnings Call, May 05, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2022-23 CI
Tatva Chintan Pharma Chem Begins Commercial Production at New Unit in Dahej, India MT
Tatva Chintan Pharma Chem Limited Announces Commencement of Commercial Production of New Facility At Dahej Manufacturing Plant CI
Transcript : Tatva Chintan Pharma Chem Limited, Q3 2023 Earnings Call, Jan 24, 2023
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Certain Equity Shares of Tatva Chintan Pharma Chem Limited are subject to a Lock-Up Agreement Ending on 26-JUL-2022. CI
Chart Tatva Chintan Pharma Chem Limited
More charts
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The Company is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,027 INR
Average target price
1,674 INR
Spread / Average Target
+63.02%
Consensus
  1. Stock Market
  2. Equities
  3. TATVA Stock
  4. News Tatva Chintan Pharma Chem Limited
  5. Tatva Chintan Pharma Chem Begins Commercial Production at New Unit in Dahej, India